Hepatic Metastasis 12 Years after Nephrectomy for Renal Cell Carcinoma
暂无分享,去创建一个
U. Motosugi | S. Tabuchi | Y. Toshimitsu | M. Aikawa | I. Koyama | K. Okamoto | Toshimasa Ishii | M. Miyazawa | K. Okada
[1] M. Gordon,et al. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma , 2008 .
[2] U. Neumann,et al. Liver Resection for Metastases from Renal Cell Carcinoma , 2007, World Journal of Surgery.
[3] D. Nagorney,et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases , 2005, Journal of Gastrointestinal Surgery.
[4] H. Bismuth,et al. Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. , 2006, HPB.
[5] T. Wilt,et al. Immunotherapy for advanced renal cell cancer. , 2015, The Cochrane database of systematic reviews.
[6] A. Muratore,et al. Extensive resections for colorectal liver metastases. , 2004, Journal of hepato-biliary-pancreatic surgery.
[7] Seth M Steinberg,et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.
[8] Ying Lu,et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. , 2002, Radiology.
[9] J Konishi,et al. Contribution of PET in the detection of liver metastases from pancreatic tumours. , 1999, Clinical radiology.
[10] H. Abdel-Nabi,et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. , 1998, Radiology.
[11] C. Stief,et al. Surgery for metachronous solitary liver metastases of renal cell carcinoma. , 1997, The Journal of urology.
[12] R. Fisher,et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] R. Fisher,et al. Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] W. Taylor,et al. Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patient survival. , 1988, The Journal of urology.
[15] S. Al-Askari,et al. Aggressive treatment of metastatic renal cancer. , 1986, The Journal of urology.
[16] J. Dekernion,et al. Prognostic factors in metastatic renal carcinoma. , 1986, The Journal of urology.
[17] S. Khoury. The treatment of metastasis from renal cell carcinoma. , 1982, Progress in clinical and biological research.
[18] J. W. Segura,et al. Renal cell carcinoma: long-term survival and late recurrence. , 1981, The Journal of urology.